Published in Oncology (Williston Park) on May 01, 2014
Comparison of five different popular scoring systems to predict nonsentinel lymph node status in patients with metastatic sentinel lymph nodes: a tertiary care center experience. Springerplus (2015) 0.77
Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy. World J Clin Oncol (2015) 0.76
Surgical breast oncologists: successful innovators and patient advocates. Oncology (Williston Park) (2014) 0.75
Modulating the extension of axillary lymphadenectomy for early stage breast cancer. J Med Life (2016) 0.75
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases. Breast Cancer Res Treat (2017) 0.75
Following the data: past, present, and future management of the axilla in breast cancer patients. Oncology (Williston Park) (2014) 0.75
Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift. Arch Pathol Lab Med (2016) 0.75
The impact of preoperative axillary ultrasonography in T1 breast tumours. Eur Radiol (2015) 0.75
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA (2011) 16.68
Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol (2002) 6.51
Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol (2005) 3.65
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51
Local therapy and survival in breast cancer. N Engl J Med (2007) 3.33
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol (2011) 3.22
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am (2003) 2.82
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med (2013) 2.76
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol (2007) 2.50
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst (2004) 2.37
Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA (2011) 2.28
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov (2012) 2.23
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.21
Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst (2009) 2.18
Does aggressive local therapy improve survival in metastatic breast cancer? Surgery (2002) 2.13
Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy. Ann Surg Oncol (2005) 2.13
Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) (2011) 2.09
Correlates of between-surgeon variation in breast cancer treatments. Med Care (2006) 2.08
Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice? Am J Clin Pathol (2012) 1.99
Beauty and the beast: management of breast cancer after plastic surgery. Ann Surg (2008) 1.98
The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Arch Pathol Lab Med (2014) 1.98
Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol (2009) 1.96
Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J (2010) 1.90
An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns (2006) 1.87
Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol (2007) 1.84
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol (2013) 1.84
Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer (2004) 1.82
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys (2007) 1.71
Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res (2005) 1.67
Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) (2007) 1.58
Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. J Clin Oncol (2009) 1.56
Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer (2007) 1.54
Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer. Cancer (2008) 1.54
Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg (2011) 1.53
Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol (2005) 1.53
What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol (2009) 1.52
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clin Cancer Res (2012) 1.50
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer (2010) 1.47
Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns (2006) 1.46
A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location. Cancer (2008) 1.41
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol (2006) 1.41
Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg (2013) 1.40
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg (2005) 1.39
Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol (2009) 1.33
Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer (2003) 1.33
Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol (2007) 1.31
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol (2002) 1.24
Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma. Changes in management and determinants of where care is delivered. Cancer (2002) 1.22
Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol (2011) 1.21
Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA (2013) 1.20
Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision? Ann Surg Oncol (2011) 1.20
Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer. Med Care (2010) 1.18
The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol (2014) 1.18
Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol (2013) 1.17
Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care (2010) 1.16
Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer (2010) 1.14
Surgeon perspectives about local therapy for breast carcinoma. Cancer (2005) 1.13
Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol (2010) 1.12
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy. Cancer (2012) 1.11
Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol (2008) 1.10
A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge. Ann Surg (2005) 1.08
Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv (2012) 1.06
Rational local therapy for breast cancer. N Engl J Med (2002) 1.05
The influence of age on the breast surgery decision-making process. Ann Surg Oncol (2007) 1.03
Nodal Irradiation after Breast-Cancer Surgery in the Era of Effective Adjuvant Therapy. N Engl J Med (2015) 1.03
Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol (2007) 1.02
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol (2014) 1.01
Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol (2013) 1.01
Coordination of breast cancer care between radiation oncologists and surgeons: a survey study. Int J Radiat Oncol Biol Phys (2011) 1.00
Radioactive seed localization with 125I for nonpalpable lesions prior to breast lumpectomy and/or excisional biopsy: methodology, safety, and experience of initial year. Health Phys (2013) 1.00
More mastectomies: is this what patients really want? J Clin Oncol (2009) 1.00
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype. Eur J Nucl Med Mol Imaging (2015) 0.98
Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. J Endocrinol (2005) 0.97
Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis (2012) 0.96
Status of postmastectomy radiotherapy in the United States: a patterns of care study. Int J Radiat Oncol Biol Phys (2004) 0.95
The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol (2014) 0.95
Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol (2010) 0.94
Margins in breast-conserving therapy: have we lost sight of the big picture? Expert Rev Anticancer Ther (2008) 0.94
Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Res Treat (2011) 0.94
MRI and breast cancer: role in detection, diagnosis, and staging. Oncology (Williston Park) (2007) 0.94
A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol (2011) 0.93
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol (2004) 0.93
Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol (2013) 0.93
Ductal lavage and ductoscopy: the opportunities and the limitations. Clin Breast Cancer (2002) 0.92
The challenge of individualizing treatments for patients with breast cancer. JAMA (2012) 0.91
Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer (2009) 0.91
Factors that influence surgical choices in women with breast carcinoma. Cancer (2002) 0.91
Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted? J Clin Oncol (2006) 0.90
Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer. Clin Breast Cancer (2005) 0.90
Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol (2014) 0.90
To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol (2011) 0.90
Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? Int J Radiat Oncol Biol Phys (2008) 0.90
Current comprehensive assessment and management of women at increased risk for breast cancer. Am J Surg (2004) 0.89